Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents. 

Technology | Stents Drug Eluting

November 9, 2017 — Abbott received European CE mark for Xience Sierra, the newest generation of the company's Xience ...

Home November 09, 2017
Home
OCT comparison between the Combo vs. Xience stents in the HARMONEE study.
Feature | Stents

November 8, 2017 – New results from the HARMONEE Japan/U.S. Registration Trial, reported by in a first report ...

Home November 08, 2017
Home
Videos | Stents Bioresorbable

A discussion with Ajay Kirtane, M.D., SM, director of the cardiac catheterization laboratories at New York-Presbyterian ...

Home November 07, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

November 6, 2017 —  The first trial to evaluate the safety of dual antiplatelet therapy (DAPT) for less than 12 months ...

Home November 06, 2017
Home
News | Stents Drug Eluting

November 6, 2017 — Elderly patients undergoing percutaneous coronary intervention (PCI) often receive bare-metal stents ...

Home November 06, 2017
Home
News | Stents Drug Eluting

November 3, 2017 — Biotronik's Orsiro drug-eluting stent (DES) demonstrated high long-term safety and clinical ...

Home November 03, 2017
Home
News | Stents Drug Eluting

November 1, 2017 — OrbusNeich reported results from the REDUCE trial in the Late-Breaking Clinical Trial session at the ...

Home November 01, 2017
Home
News | Stents Bifurcation

November 1, 2017 — The double kissing (DK) crush two-stent technique was associated with a lower rate of target lesion ...

Home November 01, 2017
Home
News | Stents Bioresorbable

October 31, 2017 – Thirty-day results from ABSORB IV, the largest randomized everolimus-eluting bioresorbable vascular ...

Home October 31, 2017
Home
News | Stents Bioresorbable

October 31, 2017 — The U.S. Food and Drug Administration (FDA) issued a warning to healthcare providers that interim ...

Home October 31, 2017
Home
News | Stents

October 27, 2017 — CeloNova BioSciences Inc. announced the U.S. Food and Drug Administration (FDA) approved expansion of ...

Home October 27, 2017
Home
News | Stents Drug Eluting

October 25, 2017 — Elixir Medical Corp. announced it will unveil a new metallic drug-eluting stent (DES) platform at ...

Home October 25, 2017
Home
News | Stents Bioresorbable

October 25, 2017 — Amaranth Medical will provide an update at the annual Transcatheter Cardiovascular Therapeutics (TCT) ...

Home October 25, 2017
Home
Abbott has pulled the Absorb Bioresorbable scaffold stent off the market.
Feature

October 2, 2017 — Here is the list of the most popular articles and videos on the Diagnostic and Interventional ...

Home October 02, 2017
Home
News | Stents Bare Metal

September 22, 2017 — Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy ...

Home September 22, 2017
Home
Subscribe Now